|
Tandem Diabetes Care Secures FDA Clearance for Control-IQ+ in Type 2 Diabetes
|
Written by: J. Smith |
Hits: 1200
|
|
Compounders Sue FDA Over Semaglutide Shortage Decision
|
Written by: J. Smith |
Hits: 1176
|
|
Lilly Expands Zepbound Vial Options, Lowers Prices for Self-Pay Patients
|
Written by: J. Smith |
Hits: 1134
|
|
FDA Warns Patients to Regularly Check Smartphone Alert Settings for Diabetes Devices
|
Written by: J. Smith |
Hits: 1326
|
|
FDA Approves Merilog, the First Rapid-Acting Insulin Biosimilar
|
Written by: J. Smith |
Hits: 1192
|
|
FDA Declares Semaglutide Shortage Resolved, Raising Concerns Over Compounded Versions
|
Written by: J. Smith |
Hits: 1070
|
|
Controversial Super Bowl Ad Sparks Debate Over Compounded GLP-1 Medications
|
Written by: J. Smith |
Hits: 1103
|
|
Novo Nordisk's CagriSema Gains Momentum Amid Investor Optimism and Legal Scrutiny
|
Written by: J. Smith |
Hits: 1180
|
|
FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes
|
Written by: J. Smith |
Hits: 998
|
|
Novo Nordisk's Amycretin Shows 22% Weight Loss in Early Trial Results
|
Written by: J. Smith |
Hits: 1121
|
